Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3595 participants.
Also called NCT05665608
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 3,595 participants
- Registry
-
NCT05665608
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Austria, Belgium, Czechia, Denmark, France, Germany, Hungary, Israel, Martinique, Netherlands, Poland, Spain, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT05665608. Randomized; no masking; primary purpose prevention. Start 2023-11-16 (actual); primary completion 2027-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
- Acronym
- PROFID EHRA
- Condition
- Sudden Cardiac Death
- Condition
- Myocardial Infarction
- Intervention (Device)
- Implantable cardioverter-defibrillator (ICD)
- Intervention (Drug)
- Optimal Medical Therapy (OMT)
- Lead sponsor
- Charite University, Berlin, Germany
Record details
- Record id
cardio:ct-nct05665608- Content hash
9158800a616831e525f923b60223562fb5e4746bf1e9b93a7ab6ea247e8fd064